Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RETRACTED: LBX2‐AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via miR‐455‐5p and miR‐491‐5p sponging
Jian Cao, Huan Wang, Guangquan Liu, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 25, Iss. 2, pp. 1178-1189
Open Access | Times Cited: 23

Showing 23 citing articles:

Construction of Ovarian Cancer Prognostic Model Based on the Investigation of Ferroptosis-Related lncRNA
Shaoyi Yang, Jie Ji, Meng Wang, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 306-306
Open Access | Times Cited: 16
The role of E2F2 in cancer progression and its value as a therapeutic target
Yang Gao, Xinjie Qiao, Zhenhui Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Ferroptosis contributes to the progression of female-specific neoplasms, from breast cancer to gynecological malignancies in a manner regulated by non-coding RNAs: Mechanistic implications
Kiavash Hushmandi, Daniel J. Klionsky, Amir Reza Aref, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 4, pp. 1159-1177
Open Access | Times Cited: 4
Cell division cycle associated 8: A novel diagnostic and prognostic biomarker for hepatocellular carcinoma
Xiaohan Cui, Qiuju Peng, Renzhi Li, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 24, pp. 11097-11112
Open Access | Times Cited: 29
LncRNA LBX2-AS1 promotes proliferation and migratory capacity of clear cell renal cell carcinoma through mitophagy
Bao Wang, Yuang Wei, Tian Han, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 3
LncRNA LBX2-AS1 inhibits acute myeloid leukemia progression through miR-455-5p/MYLIP axis
Gongli Fu, Hao Wu, Xiaomiao Wu, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24812-e24812
Open Access | Times Cited: 2
The E2F transcription factor 2: What do we know?
Luwen Li, Shiguan Wang, Yihang Zhang, et al.
BioScience Trends (2021) Vol. 15, Iss. 2, pp. 83-92
Open Access | Times Cited: 18
LINC00460 promotes pancreatic cancer progression by sponging miR‐491‐5p
Jiali Wu, Shuxin Sun, Wei Liao, et al.
The Journal of Gene Medicine (2021) Vol. 23, Iss. 6
Closed Access | Times Cited: 14
Long Noncoding RNAs in Ovarian Cancer—Functions and Clinical Applications
Lili Zhong, Xin Li, Yicun Wang, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 4
Open Access | Times Cited: 5
The role of LncRNA LBX2-AS1 in cancers: functions, mechanisms and potential clinical utility
Yuanshuai Su, Chengzhi Li, Yu Fang, et al.
Clinical & Translational Oncology (2022) Vol. 25, Iss. 2, pp. 293-305
Open Access | Times Cited: 8
Identification of lncRNAs Deregulated in Epithelial Ovarian Cancer Based on a Gene Expression Profiling Meta-Analysis
Martín Salamini-Montemurri, Mónica Lamas‐Maceiras, Lidia Lorenzo-Catoira, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10798-10798
Open Access | Times Cited: 4
A Novel Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response of Glioma
Zhikang Wu, Meimei Liu, Jinlong Fu, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 7
The Tumor Suppressor Roles and Mechanisms of MiR-491 in Human Cancers
Farzad Sadri, Seyede Fatemeh Hosseini, Atena Aghayei, et al.
DNA and Cell Biology (2022) Vol. 41, Iss. 9, pp. 810-823
Closed Access | Times Cited: 6
LncRNA LBX2-AS1 impacts osteosarcoma sensitivity to JQ-1 by sequestering miR-597-3p away from BRD4
Jiayu Li, Xuhui Yuan, Cong Ma, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
LBX2-AS1 Activates FSTL3 by Binding to Transcription Factor RARα to Foster Proliferation, Migration, and Invasion of Thyroid Cancer
Jia Li, Jie Shen, Lan Qin, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 6
Identification of Epigenetic-Dysregulated lncRNAs Signature in Osteosarcoma by Multi-Omics Data Analysis
Junchao Huang, Jingwei Zhang, Haijun Xiao
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 4
LBX2-AS1 as a Novel Diagnostic Biomarker and Therapeutic Target Facilitates Multiple Myeloma Progression by Enhancing mRNA Stability of LBX2
Haipeng Jia, Yan Liu, Sulong Lv, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 5
Genetic variants of cell cycle pathway genes are associated with head and neck squamous cell carcinoma in the Chinese population
Mo Chen, Wenmao Xu, Guiyang Wang, et al.
Carcinogenesis (2021) Vol. 42, Iss. 11, pp. 1337-1346
Closed Access | Times Cited: 5
Epigenetic regulation in ovarian cancer
Hue Vu Thi, Anh-Dao Ngo, Dinh‐Toi Chu
International review of cell and molecular biology (2024), pp. 77-98
Closed Access
Circ_0001741 exerts as a tumor promoter in ovarian cancer through the regulation of miR-491-5p/PRSS8 axis
Ding Wang, Sumin Zhang, Qiaoling Wang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
E2F2 is upregulated by the ERK pathway and regulates decidualization via MCM4
Wenling Zheng, Shanfei Zhao, Hong He, et al.
Gene (2023) Vol. 871, pp. 147400-147400
Closed Access | Times Cited: 1
A five‐gene methylation signature predicts overall survival of patients with clear cell renal cell carcinoma
Jing Xiao, Gang Xu, Yu Gong, et al.
Journal of Clinical Laboratory Analysis (2021) Vol. 35, Iss. 12
Open Access | Times Cited: 2
Page 1

Scroll to top